Literature DB >> 23306296

Evaluation of hyaluronic acid intra-articular injections in the treatment of primary and secondary osteoarthritis of the knee.

Sławomir Swięchowicz1, Alina Ostałowska, Aleksandra Kasperczyk, Dariusz Nowak, Ewa Birkner, Sławomir Kasperczyk.   

Abstract

BACKGROUND: Osteoarthritis is one of the most common locomotor conditions and the knee is the second most frequently affected articulation. One of therapeutic methods is viscosupplementation involving intra-articular injections of hyaluronic acid preparations. The aim of the study was to evaluate the clinical status and analyse selected biochemical blood parameters in patients with knee osteoarthritis after intra-articular injections of a hyaluronic acid preparation. MATERIAL/
METHODS: Blood was taken from 113 patients, 60 patients with primary and 53 patients with secondary osteoarthritis, who were administered intra-articular injections of a hyaluronic acid preparation into the affected knee, according to the schedule established in the study protocol. Concentration of lipid hydroperoxides in blood plasma was determined, along with that of malondialdehyde in erythrocytes. Plasma concentrations of ceruloplasmin, TAC, albumin, total bilirubin, and uric acid were also determined. Clinical assessment was performed using a modified HHS scale and the WOMAC questionnaire.
RESULTS: Intra-articular administration of a hyaluronic acid preparation significantly reduced pain in the knee and improved its functioning, regardless of the form of osteoarthritis. Not only clinical improvement was observed, but also beneficial changes in the blood antioxidant system.
CONCLUSIONS: Comparable clinical improvement was observed in both forms of osteoarthritis of the knee. It was also beneficial changes in blood antioxidant system, especially in the group with secondary osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23306296

Source DB:  PubMed          Journal:  Pol Orthop Traumatol        ISSN: 0009-479X


  4 in total

1.  Sorbitol-modified hyaluronic acid reduces oxidative stress, apoptosis and mediators of inflammation and catabolism in human osteoarthritic chondrocytes.

Authors:  John-Max Mongkhon; Maryane Thach; Qin Shi; Julio C Fernandes; Hassan Fahmi; Mohamed Benderdour
Journal:  Inflamm Res       Date:  2014-05-25       Impact factor: 4.575

Review 2.  Temporomandibular joint osteoarthritis: diagnosis and long-term conservative management: a topic review.

Authors:  Mythili Kalladka; Samuel Quek; Gary Heir; Eli Eliav; Muralidhar Mupparapu; Archana Viswanath
Journal:  J Indian Prosthodont Soc       Date:  2013-09-22

3.  PLGA Nanoparticles Grafted with Hyaluronic Acid to Improve Site-Specificity and Drug Dose Delivery in Osteoarthritis Nanotherapy.

Authors:  Luana Zerrillo; Maria Rosa Gigliobianco; Domenico D'Atri; Joao Pedro Garcia; Fabio Baldazzi; Yanto Ridwan; Gastón Fuentes; Alan Chan; Laura B Creemers; Roberta Censi; Piera Di Martino; Luis J Cruz
Journal:  Nanomaterials (Basel)       Date:  2022-06-30       Impact factor: 5.719

4.  A Young Patient with Temporomandibular Joint Osteoarthritis: Case Report.

Authors:  Ema Vrbanović; Iva Z Alajbeg
Journal:  Acta Stomatol Croat       Date:  2017-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.